Table 1.
Patients’ data including tumor location and size, diaphragm breathing motion in the SI direction, volume change between inhale and exhale, bronchial volume percentage to lung volume, and comorbid illness.
| Patient | Tumor | Breathing | Bronchi (vol %) | Comorbid illnessa | ||
|---|---|---|---|---|---|---|
| Location | Size (cm3) | Motion (mm) | Volume change (%) | |||
| P1 | LLL | 2.63 | 12.5 | 6 | 4 | AtrialFib, PMR, hyperthyroidism |
| P2 | RML | 21.51 | 12.5 | 5 | 3 | CHF, MI, Colon cancer |
| P3 | RML | 4.14 | 10.0 | 6 | 2 | Asthma, tonsillar and H∕N cancer |
| P4 | RUL | 2.83 | 10.0 | 10 | 5 | COPD |
| P5 | RUL | 0.67 | 12.5 | 11 | 3 | Breast and Colon Cancer |
| P6 | LLL | 1.57 | 12.5 | 8 | 5 | COPD, psoriasis |
| P7 | RLL | 4.63 | 7.5 | 13 | 6 | N∕A |
| P8 | LUL | 0.08 | 2.5 | 1 | 6 | CHF, MI, COPD, HTN, PVD |
| P9 | RUL | 59.33 | 20 | 9 | 3 | None |
| P10 | LUL | 2.05 | 5.0 | 6 | 5 | COPD, CHF, MI, PMR |
a
CHF: Congestive heart failure, COPD: Chronic obstructive pulmonary disease, HTN: Hypertension, MI: Myocardial infarction (heart attack), PMR: Polymyalgia rheumatica, and PVD: Peripheral vascular disease.